JP2017507922A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017507922A5 JP2017507922A5 JP2016547536A JP2016547536A JP2017507922A5 JP 2017507922 A5 JP2017507922 A5 JP 2017507922A5 JP 2016547536 A JP2016547536 A JP 2016547536A JP 2016547536 A JP2016547536 A JP 2016547536A JP 2017507922 A5 JP2017507922 A5 JP 2017507922A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- agonist
- igg antibody
- present
- allogeneic igg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461930386P | 2014-01-22 | 2014-01-22 | |
| US61/930,386 | 2014-01-22 | ||
| US201462066574P | 2014-10-21 | 2014-10-21 | |
| US62/066,574 | 2014-10-21 | ||
| PCT/US2015/012511 WO2015112749A2 (en) | 2014-01-22 | 2015-01-22 | Methods and compositions for antibody and antibody-loaded dendritic cell mediated therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017507922A JP2017507922A (ja) | 2017-03-23 |
| JP2017507922A5 true JP2017507922A5 (cg-RX-API-DMAC7.html) | 2018-03-01 |
Family
ID=53682123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016547536A Pending JP2017507922A (ja) | 2014-01-22 | 2015-01-22 | 抗体のためおよび抗体が充填された樹状細胞を介した療法のための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20160340439A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3096787A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2017507922A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20160106170A (cg-RX-API-DMAC7.html) |
| CN (1) | CN106170299A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015209277B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2937499A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015112749A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200079860A1 (en) * | 2015-08-06 | 2020-03-12 | Memorial Sloan Kettering Cancer Center | Methods and compositions for tumor therapy |
| CR20180229A (es) * | 2015-10-29 | 2018-08-24 | Novartis Ag | Conjugados de anticuerpos que comprenden un agonista del receptor tipo toll |
| WO2017117269A1 (en) * | 2015-12-29 | 2017-07-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for dectin-2 stimulation and cancer immunotherapy |
| US11083751B2 (en) * | 2016-02-26 | 2021-08-10 | Vib Vzw | Tumor-associated dendritic cell preparations and uses thereof |
| BR112019000071A2 (pt) | 2016-07-07 | 2019-07-02 | Bolt Biotherapeutics Inc | conjugados adjuvantes de anticorpo |
| WO2018140845A2 (en) * | 2017-01-27 | 2018-08-02 | Duke University | Bi-specific antibodies to cd64 and a disease antigen |
| US12171803B2 (en) | 2017-04-12 | 2024-12-24 | Memgen, Inc. | Methods of CD40 and toll like receptor immune activation |
| WO2019189780A1 (ja) | 2018-03-30 | 2019-10-03 | 東レ株式会社 | 癌の治療及び/又は予防用医薬組成物 |
| CN110396498A (zh) * | 2018-04-25 | 2019-11-01 | 重庆市畜牧科学院 | 体外活化记忆性b细胞成浆细胞的方法 |
| JP2021532106A (ja) | 2018-07-23 | 2021-11-25 | エンジーンアイシー モレキュラー デリバリー ピーティーワイ リミテッド | 細菌由来ミニ細胞を含む組成物およびそれを使用する方法 |
| CN120078889A (zh) * | 2019-01-28 | 2025-06-03 | 阿姆弗拉公司 | 用于治疗胰腺癌的药物组合物 |
| EP3937984A1 (en) | 2019-03-15 | 2022-01-19 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| CN110628621B (zh) * | 2019-10-28 | 2023-12-22 | 合肥中科干细胞再生医学有限公司 | 一种获得肿瘤特异性t细胞的设备和方法 |
| US11179473B2 (en) | 2020-02-21 | 2021-11-23 | Silverback Therapeutics, Inc. | Nectin-4 antibody conjugates and uses thereof |
| CA3175127A1 (en) | 2020-03-12 | 2021-09-16 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| KR20230047361A (ko) | 2020-07-01 | 2023-04-07 | 아르스 파마슈티컬스 인크. | 항-asgr1 항체 접합체 및 이의 용도 |
| EP4724498A2 (en) * | 2023-06-09 | 2026-04-15 | The Regents of the University of California | Methods for identifying and correcting tumor humoral immune dysfunction |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5650150A (en) * | 1990-11-09 | 1997-07-22 | Gillies; Stephen D. | Recombinant antibody cytokine fusion proteins |
| EP1296714B1 (en) * | 2000-06-22 | 2009-08-26 | University Of Iowa Research Foundation | Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer. |
| WO2002066044A2 (en) * | 2000-10-24 | 2002-08-29 | Immunex Corporation | Method for dendritic cells based immunotherapy of tumors using combination therapy |
| WO2007130493A2 (en) * | 2006-05-03 | 2007-11-15 | Regents Of The University Of Colorado | Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
| US20080031887A1 (en) * | 2006-06-30 | 2008-02-07 | Joseph Lustgarten | Conjugates for inducing targeted immune responses and methods of making and using same |
| BRPI0808551B1 (pt) * | 2007-03-01 | 2022-04-05 | Symphogen A/S | Composições de anticorpo para o receptor do fator de crescimento antiepidérmico recombinante, molécula de ligação bi-específica e composição farmacêutica que os compreende |
| SG189730A1 (en) * | 2008-04-02 | 2013-05-31 | Macrogenics Inc | Her2/neu-specific antibodies and methods of using same |
| WO2010132622A2 (en) * | 2009-05-14 | 2010-11-18 | The Regents Of The University Of California | Anticd20-cpg conjugates and methods of treating b cell malignancies |
| KR20130108295A (ko) * | 2010-08-13 | 2013-10-02 | 베일러 리서치 인스티튜트 | 항원-제시 세포에 항체에 대한 보조제를 직접 표적화함을 기초로 하는 신규 백신 보조제 |
| WO2012170072A1 (en) * | 2011-06-06 | 2012-12-13 | Immungene, Inc. | Engineered antibody-tnfsf member ligand fusion molecules |
| CN112587671A (zh) * | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
-
2015
- 2015-01-22 JP JP2016547536A patent/JP2017507922A/ja active Pending
- 2015-01-22 AU AU2015209277A patent/AU2015209277B2/en not_active Ceased
- 2015-01-22 WO PCT/US2015/012511 patent/WO2015112749A2/en not_active Ceased
- 2015-01-22 CA CA2937499A patent/CA2937499A1/en not_active Abandoned
- 2015-01-22 KR KR1020167021832A patent/KR20160106170A/ko not_active Withdrawn
- 2015-01-22 EP EP15740815.4A patent/EP3096787A4/en not_active Withdrawn
- 2015-01-22 US US15/112,409 patent/US20160340439A1/en not_active Abandoned
- 2015-01-22 CN CN201580015746.2A patent/CN106170299A/zh active Pending
-
2020
- 2020-08-20 US US16/998,734 patent/US20210024649A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cerundolo et al. | Harnessing invariant NKT cells in vaccination strategies | |
| Vinuesa et al. | Innate B cell helpers reveal novel types of antibody responses | |
| Demangel et al. | Interaction of dendritic cells with mycobacteria: where the action starts | |
| Shimabukuro-Vornhagen et al. | The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells | |
| Dellacherie et al. | Single‐shot mesoporous silica rods scaffold for induction of humoral responses against small antigens | |
| Houot et al. | Vaccines for lymphomas: idiotype vaccines and beyond | |
| US20110195456A1 (en) | Methods and compositions for the production of monoclonal antibodies | |
| JP2017507922A (ja) | 抗体のためおよび抗体が充填された樹状細胞を介した療法のための方法および組成物 | |
| JP6387156B2 (ja) | 乳癌再発の予防用ワクチン | |
| Yu et al. | Combinational immunotherapy with Allo-DRibble vaccines and anti-OX40 co-stimulation leads to generation of cross-reactive effector T cells and tumor regression | |
| JP2014521657A (ja) | 膵臓がんに対する樹状細胞(dc)ワクチン療法 | |
| Pieper et al. | Radiation augments the local anti-tumor effect of in situ vaccine with CpG-oligodeoxynucleotides and anti-OX40 in immunologically cold tumor models | |
| Van Dinther et al. | Comparison of protein and peptide targeting for the development of a CD169-based vaccination strategy against melanoma | |
| KR102578682B1 (ko) | Il8의 emt 경로 차단 및 암 줄기 세포 극복(il8 bloking emt pathway and overcoming cancer stem cells) | |
| JP6952603B2 (ja) | クラミジア活性化b細胞プラットフォーム及びその方法 | |
| CN102782123A (zh) | 用于抑制肿瘤细胞增殖的改进的组合物 | |
| CN103003305A (zh) | 癌症疫苗 | |
| Yang et al. | Supramolecular peptide hydrogel epitope vaccine functionalized with CAR-T cells for the treatment of solid tumors | |
| Roehnisch et al. | Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model | |
| Kehry et al. | B-cell activation by helper T-cell membranes | |
| Kwak | Translational development of active immunotherapy for hematologic malignancies | |
| Thakur et al. | In vitro synthesis of primary specific anti-breast cancer antibodies by normal human peripheral blood mononuclear cells | |
| Ge et al. | Immunotherapy of brain cancers: the past, the present, and future directions | |
| Hollander | Current vaccination strategies for the treatment of B-cell lymphoma and multiple myeloma | |
| Baio et al. | Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes |